Evaluation of the usefulness of pharmacist-led cognitive behavioral therapy for insomnia in patients with residual insomnia after depression remission

Evaluation of the usefulness of pharmacist-led cognitive behavioral therapy for insomnia - Evaluation of the usefulness of pharmacist-led cognitive behavioral therapy for insomnia in patients with residual insomnia after depression remission

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000054357

Enrollment

Registered

2024-07-01

Start date

2024-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Residual insomnia after remission of depression

Interventions

CBT-I

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients whose depression is in remission and who are taking one or more hypnotic.

Exclusion criteria

Exclusion criteria: Patients whose depression is not in remission and who are not taking hypnotic at all.

Design outcomes

Primary

Measure	Time frame
To compare changes in the DBAS-16 before and after intervention	—

Countries

Japan

Contacts

Public ContactHashimoto Yasuhiko

Kobe Gakuin University Faculty of Clinical Pharmacy

yhashi@pharm.kobegakuin.ac.jp0789741551

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026